Pharmaceuticals : Shots - Health News Pharmaceuticals
Stories About

Pharmaceuticals

Maryland's overturned law restricted the price of generic drugs, and had been hailed as a model for other states. It's one of a number of state initiatives designed to combat rapidly rising drug prices. Towfiqu Photography/Getty Images hide caption

toggle caption
Towfiqu Photography/Getty Images

When patients connect online, they often share information that reveals how treatments work in the real world. Roy Scott/Getty Images/Ikon Images hide caption

toggle caption
Roy Scott/Getty Images/Ikon Images
stevecoleimages/Getty Images

Probe Into Generic Drug Price Fixing Set To Widen

  • Download
  • <iframe src="https://www.npr.org/player/embed/590217561/591423244" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Jessica Morris prepares to inject a blood-clotting protein into son Landon's arm at their home in Yuba City, Calif. Heidi de Marco/Kaiser Health News hide caption

toggle caption
Heidi de Marco/Kaiser Health News

Miracle Of Hemophilia Drugs Comes At A Steep Price

  • Download
  • <iframe src="https://www.npr.org/player/embed/589469361/590974657" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Little, Brown and Company

Long-Term Effects Of Psychotropic Drugs Are 'Cloaked In Mystery'

  • Download
  • <iframe src="https://www.npr.org/player/embed/589081018/589238184" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Ronald Cirillo helps Deborah Hatfield fill out paperwork at a Florida clinic, before running a test to see whether she has hepatitis C. Daylina Miller/Health News Florida hide caption

toggle caption
Daylina Miller/Health News Florida

From Retirement To The Front Lines Of Hepatitis C Treatment

  • Download
  • <iframe src="https://www.npr.org/player/embed/567750728/575168322" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Scott Gottlieb, Food and Drug Administration commissioner, told Kaiser Health News the incentives intended to spur development of drugs for rare diseases deserve a fresh look. J. Scott Applewhite/AP hide caption

toggle caption
J. Scott Applewhite/AP

With drug prices in the election spotlight, the pharmaceutical industry's main trade group raised its revenue and spending. PeopleImages/Getty Images hide caption

toggle caption
PeopleImages/Getty Images

Peter Saltonstall, president of the National Organization of Rare Disorders, speaks at a rally Tuesday in support of tax credits for companies that develop drugs for rare diseases. Sarah Jane Tribble/KHN hide caption

toggle caption
Sarah Jane Tribble/KHN

Jared Haley, general manager of the C-Axis plant in Caguas, Puerto Rico, says computer-operated milling machines like this one can cost more than a half-million dollars. Heat and humidity in the plant after Hurricane Maria left many of the machines inoperable, Haley says. Greg Allen/NPR hide caption

toggle caption
Greg Allen/NPR

Puerto Rico's Medical Manufacturers Worry Federal Tax Plan Could Kill Storm Recovery

  • Download
  • <iframe src="https://www.npr.org/player/embed/566771228/566808704" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Speaker of the House Paul Ryan, center, and other lawmakers have a plan to overhaul the tax code that includes a provision that would repeal a tax credit for makers of drugs for rare diseases. Alex Wong/Getty Images hide caption

toggle caption
Alex Wong/Getty Images